Syra Health (SYRA) Registration Filing summary

Company overview and business model

• Operates as a healthcare services provider focused on preventative health, holistic wellness, health education, and equitable healthcare across diverse patient demographics.

• Offers end-to-end solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce services.

• Key products include Syrenity, an AI-driven mental health app, and digital health platforms such as SyraBot and CarePlus.

• Targets payers, providers, life sciences organizations, academic institutions, and government agencies.

• Growth strategy includes expanding geographically, investing in partnerships, and potential acquisitions to enhance service lines.

Financial performance and metrics

• Reported revenues of approximately $6.0 million for the nine months ended September 30, 2024, $5.5 million for 2023, and $5.6 million for 2022.

• Public float as of January 7, 2025, was $6,624,952 based on 8,964,753 shares held by non-affiliates at $0.739 per share.

• Independent auditor expressed substantial doubt about ability to continue as a going concern.

Use of proceeds and capital allocation

• Net proceeds intended for general corporate purposes, including sales and marketing, operational costs, product development, manufacturing expansion, and working capital.

• May use proceeds to repay debt or invest in/acquire complementary businesses, products, or technologies, though no current commitments exist.

• Management retains broad discretion over allocation of proceeds.